{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T08:20:13Z","timestamp":1772180413073,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T00:00:00Z","timestamp":1601856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013103","name":"Shanghai General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013103","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.biopha.2020.110856","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T18:49:41Z","timestamp":1603910981000},"page":"110856","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["C-CBL is required for inhibition of angiogenesis through modulating JAK2\/STAT3 activity in ROP development"],"prefix":"10.1016","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7734-8254","authenticated-orcid":false,"given":"Shimei","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dandan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jami","family":"Willette-Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Lewandoski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinling","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"379","key":"10.1016\/j.biopha.2020.110856_bib0005","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(12)60820-4","article-title":"National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications","author":"Blencowe","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2020.110856_bib0010","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/bjo.2010.201079","article-title":"Seventy years of retinopathy of prematurity","volume":"95","author":"Aclimandos","year":"2011","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.biopha.2020.110856_bib0015","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1172\/JCI42142","article-title":"Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life","volume":"120","author":"Sapieha","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2020.110856_bib0020","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","article-title":"Retinopathy of prematurity","volume":"382","author":"Hellstr\u00f6m","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2020.110856_bib0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.addr.2018.03.013","article-title":"Controlled release technology for anti-angiogenesis treatment of posterior eye diseases: current status and challenges","volume":"126","author":"Lau","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2020.110856_bib0030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/aos.12049","article-title":"The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge","volume":"92","author":"Cavallaro","year":"2014","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.biopha.2020.110856_bib0035","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"165","key":"10.1016\/j.biopha.2020.110856_bib0040","article-title":"Retinopathy of prematurity: inflammation, choroidal degeneration, and novel promising therapeutic strategies","volume":"14","author":"Rivera","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.biopha.2020.110856_bib0045","first-page":"20","article-title":"Vascular and neuronal protection in the developing retina: potential therapeutic targets for retinopathy of prematurity","author":"Tsang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2020.110856_bib0050","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.preteyeres.2011.11.003","article-title":"From oxygen to erythropoietin: relevance of hypoxia for retinal development, health and disease","volume":"31","author":"Caprara","year":"2012","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.biopha.2020.110856_bib0055","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s10456-018-9618-5","article-title":"Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy","volume":"21","author":"Simmons","year":"2018","journal-title":"Angiogenesis"},{"key":"10.1016\/j.biopha.2020.110856_bib0060","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ophtha.2014.07.050","article-title":"Pathophysiology and mechanisms of severe retinopathy of prematurity","volume":"122","author":"Hartnett","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.biopha.2020.110856_bib0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ophtha.2009.06.048","article-title":"Antiangiogenic approaches to age-related macular degeneration today","volume":"116","author":"Bressler","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.biopha.2020.110856_bib0070","doi-asserted-by":"crossref","first-page":"954","DOI":"10.2337\/db07-1524","article-title":"Protective effect of perindopril on diabetic retinopathy is associated with decreased vascular endothelial growth factor-to-pigment epithelium-derived factor ratio: involvement of a mitochondria-reactive oxygen species pathway","volume":"58","author":"Zheng","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2020.110856_bib0075","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1167\/iovs.09-3511","article-title":"Inhibition of JAK2\/STAT3-mediated VEGF upregulation under high glucose conditions by PEDF through a mitochondrial ROS pathway in vitro","volume":"51","author":"Zheng","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2020.110856_bib0080","article-title":"Anti-vascular endothelial growth factor for neovascular age-related macular degeneration","volume":"3","author":"Solomon","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.biopha.2020.110856_bib0085","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nrm1762","article-title":"The Cbl interactome and its functions","volume":"6","author":"Schmidt","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2020.110856_bib0090","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1002\/j.1460-2075.1993.tb05851.x","article-title":"The truncation that generated the v-cbl oncogene reveals an ability for nuclear transport, DNA binding and acute transformation","volume":"12","author":"Blake","year":"1993","journal-title":"EMBO J."},{"key":"10.1016\/j.biopha.2020.110856_bib0095","first-page":"8","article-title":"c-Cbl: an important regulator and a target in angiogenesis and tumorigenesis","author":"Lyle","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2020.110856_bib0100","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1073\/pnas.0700809104","article-title":"A critical role for the E3-ligase activity of c-Cbl in VEGFR-2-mediated PLCgamma1 activation and angiogenesis","volume":"104","author":"Singh","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2020.110856_bib0105","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/523415","article-title":"Identification of age-related macular degeneration related genes by applying shortest path algorithm in protein-protein interaction network","volume":"2013","author":"Zhang","year":"2013","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.biopha.2020.110856_bib0110","doi-asserted-by":"crossref","first-page":"6803","DOI":"10.1167\/iovs.10-5255","article-title":"Role of c-Cbl-dependent regulation of phospholipase Cgamma1 activation in experimental choroidal neovascularization","volume":"51","author":"Husain","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2020.110856_bib0115","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.preteyeres.2015.06.002","article-title":"Molecular pathogenesis of retinal and choroidal vascular diseases","volume":"49","author":"Campochiaro","year":"2015","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.biopha.2020.110856_bib0120","first-page":"101","article-title":"Oxygen-induced retinopathy in the mouse","volume":"35","author":"Smith","year":"1994","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2020.110856_bib0125","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/nprot.2009.187","article-title":"Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis","volume":"4","author":"Connor","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biopha.2020.110856_bib0130","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1056\/NEJMra1208129","article-title":"Mechanisms and management of retinopathy of prematurity","volume":"367","author":"Hartnett","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2020.110856_bib0135","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.preteyeres.2017.09.002","article-title":"Pathophysiology, screening and treatment of ROP: a multi-disciplinary perspective","volume":"62","author":"Chan-Ling","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.biopha.2020.110856_bib0140","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1101\/gad.297135.117","article-title":"CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies","volume":"31","author":"Lv","year":"2017","journal-title":"Genes Dev."},{"key":"10.1016\/j.biopha.2020.110856_bib0145","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1167\/iovs.08-1754","article-title":"Role of NADPH oxidase and Stat3 in statin-mediated protection against diabetic retinopathy","volume":"49","author":"Al-Shabrawey","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2020.110856_bib0150","doi-asserted-by":"crossref","first-page":"19459","DOI":"10.1074\/jbc.M113.475087","article-title":"CBL linker region and RING finger mutations lead to enhanced granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling via elevated levels of JAK2 and LYN","volume":"288","author":"Javadi","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2020.110856_bib0155","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1042\/CS20120212","article-title":"Reactive oxygen species, Nox and angiotensin II in angiogenesis: implications for retinopathy","volume":"124","author":"Wilkinson-Berka","year":"2013","journal-title":"Clin. Sci. (Lond.)"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220310489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220310489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:12:35Z","timestamp":1760098355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220310489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":31,"alternative-id":["S0753332220310489"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110856","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"C-CBL is required for inhibition of angiogenesis through modulating JAK2\/STAT3 activity in ROP development","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110856","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"110856"}}